These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 10566233

  • 1. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
    Kassa J, Bajgar J.
    Cas Lek Cesk; 1999 Aug 30; 138(17):532-5. PubMed ID: 10566233
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
    Kassa J.
    Ceska Slov Farm; 1999 Jan 30; 48(1):44-7. PubMed ID: 10376416
    [Abstract] [Full Text] [Related]

  • 3. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.
    Toxicol Mech Methods; 2011 Mar 30; 21(3):241-5. PubMed ID: 21142778
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the reactivation effects of the HI-6 oxime and obidoximeon cyclosin-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
    Kassa J.
    Ceska Slov Farm; 1998 Feb 30; 47(1):47-50. PubMed ID: 9600150
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K, Cabal J, Kassa J.
    Pharmazie; 2004 Oct 30; 59(10):795-8. PubMed ID: 15544060
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats.
    Kassa J.
    Hum Exp Toxicol; 1998 Jun 30; 17(6):331-5. PubMed ID: 9688357
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug 20; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 9. [The effect of pharmacologic prophylaxis with Panpal on acetylcholinesterase activity in the diaphragm and various parts of the brain in rats during treated and untreated Soman poisoning].
    Kassa J.
    Cas Lek Cesk; 1998 May 18; 137(10):299-302. PubMed ID: 9650360
    [Abstract] [Full Text] [Related]

  • 10. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J, Hajek P, Zdarova JK, Kassa J, Paseka A, Slizova D, Krs O, Kuca K, Jun D, Fusek J, Capek L.
    J Enzyme Inhib Med Chem; 2010 Dec 18; 25(6):790-7. PubMed ID: 21054236
    [Abstract] [Full Text] [Related]

  • 11. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L, Kuca K, Jun D, Kunesova G.
    Int J Toxicol; 2005 Dec 18; 24(6):399-402. PubMed ID: 16393932
    [Abstract] [Full Text] [Related]

  • 12. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Musilek K, Kuca K, Jung YS.
    J Enzyme Inhib Med Chem; 2010 Aug 18; 25(4):480-4. PubMed ID: 20233085
    [Abstract] [Full Text] [Related]

  • 13. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Bajgar J.
    Toxicol Mech Methods; 2009 Nov 18; 19(9):547-51. PubMed ID: 19839724
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J, Sepsova V, Matouskova L, Horova A, Musilek K.
    Toxicol Mech Methods; 2015 Mar 18; 25(3):229-33. PubMed ID: 25894563
    [Abstract] [Full Text] [Related]

  • 15. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J, Jun D, Karasova J, Bajgar J, Kuca K.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):425-7. PubMed ID: 18547554
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K, Cabal J, Kassa J, Jun D, Hrabinová M.
    Acta Medica (Hradec Kralove); 2005 Sep 25; 48(2):81-6. PubMed ID: 16259317
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J, Kuca K, Cabal J, Paar M.
    J Toxicol Environ Health A; 2006 Oct 25; 69(20):1875-82. PubMed ID: 16952906
    [Abstract] [Full Text] [Related]

  • 18. Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxication.
    Øydvin OK, Tansø R, Aas P.
    Eur J Pharmacol; 2005 Jun 15; 516(3):227-34. PubMed ID: 15967427
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J.
    Clin Toxicol (Phila); 2009 Jan 15; 47(1):72-6. PubMed ID: 18686075
    [Abstract] [Full Text] [Related]

  • 20. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M.
    J Toxicol Environ Health A; 2006 Aug 15; 69(15):1431-40. PubMed ID: 16766478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.